Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Analgesic/alcohol warning should specify active ingredient only -- Warner-Lambert.

This article was originally published in The Tan Sheet

Executive Summary

ANALGESIC/ALCOHOL WARNING ACTIVE INGREDIENT NAME REFERENCE ONLY, "i.e., acetaminophen, aspirin, ibuprofen, etc.," is "appropriate and necessary," whereas using a product's brand name is not, Warner-Lambert asserts in Jan. 27 comments to FDA on its proposed alcohol interaction warning for OTC analgesics. The company, which markets 19 cough/cold, allergy and sinus products containing acetaminophen, also suggests substituting a more general warning for the organ-specific warnings proposed by the agency in its Nov. 14 rulemaking notice ("The Tan Sheet" Nov. 17, 1997, p. 2).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088073

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel